Freestone Capital Holdings, LLC Amgen Inc Transaction History

Freestone Capital Holdings, LLC

$2.9 Billion
Q3 2024

A detailed history of Freestone Capital Holdings, LLC transactions in Amgen Inc stock. As of the latest transaction made, Freestone Capital Holdings, LLC holds 13,187 shares of AMGN stock, worth $3.9 Million. This represents 0.15% of its overall portfolio holdings.

Number of Shares

13,187

Previous 13,256 0.52%

Holding current value

$3.9 Million

Previous $4.14 Million 2.58%

% of portfolio

0.15%

Previous 0.15%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$309.38 - $337.38 $21,347 - $23,279	-69 Reduced 0.52%	13,187 $4.25 Million
Q2 2024 Aug 13, 2024	BUY	$262.75 - $319.31 $151,606 - $184,241	577 Added 4.55%	13,256 $4.14 Million
Q1 2024 May 14, 2024	SELL	$268.87 - $324.56 $26,080 - $31,482	-97 Reduced 0.76%	12,679 $3.6 Million
Q4 2023 Feb 13, 2024	SELL	$255.7 - $288.46 $55,742 - $62,884	-218 Reduced 1.68%	12,776 $3.68 Million
Q3 2023 Nov 14, 2023	BUY	$218.65 - $271.46 $69,093 - $85,781	316 Added 2.49%	12,994 $3.49 Million
Q2 2023 Aug 09, 2023	SELL	$214.27 - $253.37 $177,201 - $209,536	-827 Reduced 6.12%	12,678 $2.81 Million
Q1 2023 May 12, 2023	SELL	$225.79 - $275.2 $60,511 - $73,753	-268 Reduced 1.95%	13,505 $3.26 Million
Q4 2022 Feb 13, 2023	SELL	$229.03 - $291.01 $1.13 Million - $1.44 Million	-4,936 Reduced 26.38%	13,773 $3.62 Million
Q3 2022 Nov 09, 2022	SELL	$224.46 - $253.15 $1.32 Million - $1.49 Million	-5,893 Reduced 23.95%	18,709 $4.22 Million
Q2 2022 Aug 09, 2022	SELL	$230.71 - $256.74 $1.45 Million - $1.61 Million	-6,272 Reduced 20.31%	24,602 $5.99 Million
Q1 2022 May 12, 2022	SELL	$219.27 - $242.57 $122,133 - $135,111	-557 Reduced 1.77%	30,874 $7.47 Million
Q4 2021 Feb 14, 2022	SELL	$198.88 - $227.6 $252,776 - $289,279	-1,271 Reduced 3.89%	31,431 $7.07 Million
Q3 2021 Nov 15, 2021	SELL	$212.27 - $248.7 $1.71 Million - $2.01 Million	-8,074 Reduced 19.8%	32,702 $6.95 Million
Q2 2021 Aug 16, 2021	BUY	$233.58 - $259.14 $4,671 - $5,182	20 Added 0.05%	40,776 $9.94 Million
Q1 2021 May 17, 2021	SELL	$221.91 - $258.6 $940,232 - $1.1 Million	-4,237 Reduced 9.42%	40,756 $10.1 Million
Q4 2020 Feb 16, 2021	BUY	$216.38 - $257.67 $485,123 - $577,696	2,242 Added 5.24%	44,993 $10.3 Billion
Q3 2020 Nov 06, 2020	BUY	$234.65 - $260.95 $261,165 - $290,437	1,113 Added 2.67%	42,751 $10.9 Million
Q2 2020 Aug 04, 2020	BUY	$197.81 - $242.74 $231,833 - $284,491	1,172 Added 2.9%	41,638 $9.82 Million
Q1 2020 May 12, 2020	SELL	$182.24 - $241.7 $1.18 Million - $1.57 Million	-6,502 Reduced 13.84%	40,466 $8.2 Million
Q4 2019 Feb 04, 2020	BUY	$189.21 - $243.2 $1.49 Million - $1.92 Million	7,894 Added 20.2%	46,968 $11.3 Million
Q3 2019 Nov 07, 2019	BUY	$174.11 - $208.62 $8,531 - $10,222	49 Added 0.13%	39,074 $7.56 Million
Q2 2019 Aug 05, 2019	SELL	$166.7 - $195.41 $8.2 Million - $9.62 Million	-49,211 Reduced 55.77%	39,025 $7.19 Million
Q1 2019 May 08, 2019	SELL	$180.87 - $203.88 $4.82 Million - $5.43 Million	-26,640 Reduced 23.19%	88,236 $16.8 Million
Q4 2018 Feb 12, 2019	SELL	$178.4 - $208.25 $1.59 Million - $1.85 Million	-8,899 Reduced 7.19%	114,876 $22.4 Million
Q3 2018 Nov 13, 2018	SELL	$185.29 - $208.89 $15,564 - $17,546	-84 Reduced 0.07%	123,775 $25.7 Million
Q2 2018 Aug 14, 2018	BUY	$166.05 - $186.51 $12.8 Million - $14.4 Million	77,225 Added 165.6%	123,859 $22.9 Million
Q1 2018 May 15, 2018	BUY	$169.43 - $198.0 $1.61 Million - $1.88 Million	9,487 Added 25.54%	46,634 $7.95 Million
Q4 2017 Feb 13, 2018	BUY	$168.79 - $188.59 $654,398 - $731,163	3,877 Added 11.65%	37,147 $6.46 Million
Q3 2017 Nov 14, 2017	BUY	$167.29 - $191.0 $165,115 - $188,517	987 Added 3.06%	33,270 $6.2 Million
Q2 2017 Aug 15, 2017	BUY	N/A	32,283	32,283 $5.56 Million

Others Institutions Holding AMGN

# of Institutions

3,113

Shares Held

410M

Call Options Held

Put Options Held

6.15M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $158B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Freestone Capital Holdings, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Freestone Capital Holdings, LLC with notifications on news.

Account

Freestone Capital Holdings, LLC Amgen Inc Transaction History